Investor &
Media Relations

THE FUNDAMENT OF MEDARTIS SUCCESS.

15 years of continuous innovation in internal fixation

granted patents70

pending patents36

patent families21

Sold in countries50

Financial calendar

03.01.2022

Start of "Quiet Period"

08.03.2022

2021 Full-year results

06.04.2022

Annual General Meeting 2022

Ad hoc-News

Ad-hoc releases pursuant to art. 53 LR.

Company & Product News

FINANCIAL REPORTS

All necessary financial information of the company at a glance.

Key Figures full-year 2020

Share Information

Corporate Governance

Medartis relies on efficient cooperation between the Board of Directors and the company management. We respect the interests of our shareholders and rely on clear rules in addition to open, transparent corporate communication.

NAMEPOSITIONCOMMITTEE MEMBERSHIPFIRST ELECTEDEND CURRENT PERIOD 
Marco GadolaChairman-20212022+
Dr. h.c. Thomas StraumannVice ChairmanMember of the SIC  19982022+
Dominik EllenriederMember of the BoardChairman of the HRCC
Member of the SIC
20002022+
Willi MieschMember of the BoardChairman of the SIC20102022+
Dr. Jürg GreuterMember of the Board-19972022+
Dr. med. Daniel B. HerrenMember of the BoardMember of the HRCC
Member of the SIC
20172022+
Roland HessMember of the BoardChairman of the FAC20172022+
Damien TappyMember of the BoardMember of the HRCC
Member of the FAC
20182022+

 

HRCC = Human Resources and Compensation Committee | FAC = Finance and Audit Committee | SIC = Strategy and Innovation Committee

Analyst Coverage

The following analysts evaluate the performance of Medartis stock and the investment opportunities for investors.

CREDIT SUISSE
Christoph Gretler

Uetlibergstr. 231
CH-8045 Zurich

Zürcher Kantonalbank
Mr Daniel Buchta

Bahnhofstrasse 9
CH-8001 Zurich

Bryan Garnier & Co.
Mr. Dylan van Haaften

26 Avenue des Champs-Elysées
FRA-75008 Paris

OCTAVIAN
Frau Tanya Hansalik

Hottingerstrasse 12
CH-8032 Zurich

Annual General Meeting

Subscribe to ad hoc-News

Would you like to be informed about Medartis at first hand? Register and receive our news in electronic form.

FABIAN HILDBRAND

Head of Corporate Communications

Medartis AG
Hochbergerstrasse 60E
4057 Basel
Schweiz

Phone direct +41 (0)61 633 37 36
Phone switchboard +41 (0)61 633 34 34


Journalists and members of the media:
corporate.communication@medartis.com

Shareholders and investors:
investor.relations@medartis.com